BioNTech lung cancer drug extends survival versus chemotherapy
--------------------------------------------------------------------
Source: The Japan Times
Published: 2026-09-14 21:57 UTC+10:00
Section: WORLD
Factuality Score: 95
Opinion Category: Neutral
Topics: Health, Drugs, World News
--------------------------------------------------------------------
Snippet:
BioNTech said its experimental drug gotistobart nearly doubled the median survival of patients with an aggressive form of lung cancer compared to chemotherapy.
--------------------------------------------------------------------